• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

FDA's Criminal Investigation Head to Leave as Trump Takes Office

Article

January 04, 2017

Reuters reports that George Karavetsos, director of the Food and Drug Administration's Office of Criminal Investigations (OCI), is to leave the agency.   Karavetsos has been OCI director since January 2015. The report adds that Karavestos's "last day will be Jan. 20, the day Donald Trump is sworn in as president".   http://www.reuters.com/article/us-usa-fda-moves-idUSKBN14N1SA  

Recent Videos